NF2 Therapeutics, Inc.
PrivateLast Round
Angel
Jan 1, 2022
Company Overview
NF2 Therapeutics, Inc. is a biotechnology company that develops therapies for neurofibromatosis type 2 and related disorders.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
NF2 Therapeutics, Inc. Comparables
Compare NF2 Therapeutics, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Mulberry Biotherapeutics | 86% | |
| Santo Therapeutics | 84% | |
| Merck | 66% | |
NF2 Therapeutics, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Angel | Jan 1, 2022 |
NF2 Therapeutics, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Beacon Angels | Angel |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 1, 2022
Beacon Angels participated in the round.
NF2 Therapeutics, Inc. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about NF2 Therapeutics, Inc.'s valuation, stock price, and market status.